Lake Street Advisors Group LLC bought a new stake in Invesco Nasdaq Biotechnology ETF (NASDAQ:IBBQ – Free Report) in the first quarter, according to the company in its most recent Form 13F filing with the SEC. The fund bought 12,917 shares of the company’s stock, valued at approximately $286,000. Lake Street Advisors Group LLC owned about 0.88% of Invesco Nasdaq Biotechnology ETF at the end of the most recent quarter.
Separately, Eudaimonia Partners LLC bought a new stake in Invesco Nasdaq Biotechnology ETF during the 1st quarter valued at approximately $923,000.
Invesco Nasdaq Biotechnology ETF Stock Performance
Shares of IBBQ traded up $0.43 during mid-day trading on Thursday, reaching $24.51. The company had a trading volume of 6,048 shares, compared to its average volume of 15,800. The firm has a 50-day moving average price of $22.83 and a 200 day moving average price of $22.19. Invesco Nasdaq Biotechnology ETF has a 52 week low of $18.18 and a 52 week high of $24.74. The company has a market capitalization of $36.03 million, a price-to-earnings ratio of 17.39 and a beta of 0.61.
Invesco Nasdaq Biotechnology ETF Increases Dividend
About Invesco Nasdaq Biotechnology ETF
The Invesco Nasdaq Biotechnology ETF (IBBQ) is an exchange-traded fund that is based on the NASDAQ / Biotechnology index, a modified market-cap-weighted index of US biotechnology and pharmaceutical companies listed on the NASDAQ. IBBQ was launched on Jun 11, 2021 and is managed by Invesco.
Read More
- Five stocks we like better than Invesco Nasdaq Biotechnology ETF
- Roth IRA Calculator: Calculate Your Potential Returns
- Top 3 Small Cap Stocks Emerging as Rotation Winners
- Trading Halts Explained
- Bargain Alert: 3 Stocks Worth Watching While The Market Cools
- Are Penny Stocks a Good Fit for Your Portfolio?
- Qualcomm Stock Could Be On The Verge of an Impressive Rally
Receive News & Ratings for Invesco Nasdaq Biotechnology ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Invesco Nasdaq Biotechnology ETF and related companies with MarketBeat.com's FREE daily email newsletter.